Edition:
United Kingdom

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

16.04USD
18 Jan 2019
Change (% chg)

$-0.53 (-3.20%)
Prev Close
$16.57
Open
$16.75
Day's High
$16.75
Day's Low
$15.58
Volume
178,698
Avg. Vol
293,348
52-wk High
$17.93
52-wk Low
$6.76

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

  FATE.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.96 -- --
ROI: -72.35 8.99 14.48
ROE: -93.05 10.13 15.99

Earnings vs. Estimates